Company / Revenue per Share
Innoviva, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$6.56
FY2025
5-year range
$3.86 / $6.56
FY2021-FY2025
Trend
+15.8%
vs FY2024
Sector context
#59 of 154
Health Care
What the data says
At $6.56, Innoviva, Inc.'s revenue per share ranks #59 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $0.35 in FY2017 to $6.56 in FY2025.
Based on SEC 10-K filings.
6.56 in FY2025 with a 5-year CAGR of +14.6%.
Improved from $4.49 to $6.56 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- +14.6%
- 10-Year CAGR
- -
Sector benchmark
#59 of 154 in Health CareTop 38% of 154This company $6.56 Sector average $10.35
▼
-36.6% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 15.8% year-over-year.
- Ranks #59 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.56 | +15.8% |
| FY2024 | $5.67 | +26.3% |
| FY2023 | $4.49 | -7.3% |
| FY2022 | $4.84 | +25.3% |
| FY2021 | $3.86 | +16.2% |
| FY2020 | $3.33 | +54.8% |
| FY2019 | $2.15 | +62.6% |
| FY2018 | $1.32 | +276.4% |
| FY2017 | $0.35 | -70.6% |
| FY2016 | $1.19 | +126.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026